Comprehensive tracking of grants, pitch competitions, and conferences for advancing research in Alzheimer's, PSP, CBD, and related tauopathies.
Supports continuity of funding for ongoing research in Alzheimer's, Parkinson's, and other neurodegenerative disorders
Supports investigators with substantial contributions to neuroscience and AD/ADRD research
Funds early-career investigators in Alzheimer's and related dementias research
Seed funding up to $100,000 for 1-2 year studies in PSP/CBD fundamental neurobiology and therapeutics/biomarkers
Addresses biological, social and environmental factors affecting neurodegenerative disorders. Highly relevant for Alzheimer's, PSP, CBD, tauopathy research
€300,000 total annual allocation for brain and nervous system disease research
Pre-clinical/clinical testing for Parkinson's. Awards $250K-$2M+
IND-enabling studies and early-stage clinical trials for novel and repurposed drugs
40+ finalists pitch to investors and industry leaders. <20 employees, <$10M raised. High-visibility platform.
6-minute pitch to jury of investors and pharma dealmakers. <3 years old, ≤€10M funding, <25 employees
Life sciences/health tech startups. <50 employees, EU-based, ≤10 years old. Prestigious European program
Open to all biomedical startups from concept to pre-IPO
Focus: Neurodegenerative diseases, Alzheimer's, Parkinson's, clinical trials, therapy, diagnostics
Main event in neurodegenerative diseases. Highly relevant for PSP, CBD, tauopathies. 5,500+ participants from 70+ countries
Focus: Tau research, interdisciplinary perspectives
Critical for tauopathy focus (PSP, CBD, Alzheimer's). Network with leading tau researchers and major funders
Focus: Biotechnology, biopharma innovation, partnerships, investment
World's largest biotech partnering event. Critical for business development, investor meetings, strategic partnerships
Focus: Dementia science, Alzheimer's disease, basic and clinical research
World's largest dementia research forum. Essential for Alzheimer's and tauopathy research
Focus: PSP and CBD research, preclinical and clinical neuroscience
Directly relevant to PSP/CBD therapeutic focus. Latest breakthroughs from distinguished neuroscientists worldwide
Focus: Alzheimer's clinical trials, diagnostics, therapeutics
Focused on Alzheimer's clinical trials. Essential as therapeutics move toward clinical development